1Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci USA, 2003,100 ( 7 ) : 3983 -3988.
2Klevebring D, Rosin G, Ma R, et al. Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo [ J ]. Breast Cancer Res ,2014,16 (4) : R72.
3Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2 + and ABCG2 - cancer cells are similarly tumorigenic [ J ]. Cancer Res, 2005,65 (14) :6207 - 6219.
4Dontu G. Breast cancer stem celhnarkers-the rocky road to clinical applications [ J ]. Breast Cancer Res, 2008, 10 (5) :110.
5Clarke M F, Dick J E, Dirks P B, et al. Cancer stem cells- perspectives on current status and future directions:AACR Workshop on cancer stem cells [ J ]. Cancer Res,2006,66 (19) :9339 - 9344.
6Dontu G, E1-Ashry D, Wicha M S. Breast cancer, stem/ progenitor cells and the estrogen receptor [ J ]. Trends Endoerinol Metab, 2004,15 ( 5 ) : 193 - 197.
7Stephens PJ,Tarpey PS, Davies H,et al. The landscape of cancer genes and mutational processes in breast eancer [ J ]. Nature ,2012,486 ( 7403 ) :400 - 404.
8Vaillant F, Asselin-Labat ML, Shackleton M, et al. The emerging picture of the mouse mammary stem cell [ J ]. Stem Cell Rev ,2007,3 ( 2 ) : 114 - 123.
9Liu S, Ginestier C, Charafe-Jauffret E, et al. BRCA1 regulates human mammary stem/progenitor cell fate [ J ]. Proc Natl Acad Sci USA ,2008,105 (5) :1680 -1685.
10Nigam A. Breast cancer stem cells, pathways and therapeutic perspectives 2011 [ J ]. Indian J Surg, 2013, 75(3) :170 - 180.
